UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024034
Receipt number R000027641
Scientific Title Investigation to evaluate the efficacy of novel measurement method for fatigue.
Date of disclosure of the study information 2016/12/01
Last modified on 2017/10/02 18:06:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigation to evaluate the efficacy of novel measurement method for fatigue.

Acronym

Investigation to evaluate the efficacy of novel measurement method for fatigue.

Scientific Title

Investigation to evaluate the efficacy of novel measurement method for fatigue.

Scientific Title:Acronym

Investigation to evaluate the efficacy of novel measurement method for fatigue.

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy of novel measurement method for fatigue.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Comparison between data from autonomic nerve function measured by novel device and standard device.

Key secondary outcomes

Subjective fatigue
Cognitive function


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

50 years-old >

Gender

Male and Female

Key inclusion criteria

Healthy persons who are aged from 20 to 49 years.

Key exclusion criteria

Persons who have medical history such as neurological disorder, mental disorder, vision disorder and other serious disease.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masaaki Tanaka

Organization

Osaka City University

Division name

Center for Health Science Innovation

Zip code


Address

9F, Tower-C, Knowledge Capital, Grand Front Osaka, 3-1 Ofuka-cho, Kita-ku, Osaka 530-0011, Japan.

TEL

+81-6-6485-0288

Email

chsi-b@ado.osaka-cu.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kei Mizuno

Organization

Osaka City University

Division name

Center for Health Science Innovation

Zip code


Address

9F, Tower-C, Knowledge Capital, Grand Front Osaka, 3-1 Ofuka-cho, Kita-ku, Osaka 530-0011, Japan.

TEL

+81-6-6485-0288

Homepage URL


Email

chsi-b@ado.osaka-cu.ac.jp


Sponsor or person

Institute

Osaka City University Center for Health Science Innovation

Institute

Department

Personal name



Funding Source

Organization

Ricoh Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大阪市立大学健康科学イノベーションセンター(大阪府)


Other administrative information

Date of disclosure of the study information

2016 Year 12 Month 01 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2016 Year 03 Month 11 Day

Date of IRB


Anticipated trial start date

2016 Year 07 Month 02 Day

Last follow-up date

2016 Year 07 Month 09 Day

Date of closure to data entry

2017 Year 02 Month 06 Day

Date trial data considered complete

2017 Year 03 Month 08 Day

Date analysis concluded



Other

Other related information

Study design:Prospective study

Subject recruitment method:Website of Osaka City University Center for Health Science Innovation from May 2 to 27 in 2016.


Management information

Registered date

2016 Year 09 Month 13 Day

Last modified on

2017 Year 10 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027641


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name